News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
485,972 Results
Type
Article (8019)
Company Profile (140)
Press Release (477812)
Multimedia
Podcasts (4)
Webinars (6)
Section
Business (166868)
Career Advice (304)
Deals (25740)
Drug Delivery (7)
Drug Development (52875)
Employer Resources (14)
FDA (9764)
Job Trends (8574)
News (238333)
Policy (17905)
Tag
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (6)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (1)
2027 Genetown Standard (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (488)
Accelerated approval (26)
ADA (18)
Adcomms (1)
Allergies (97)
Alliances (33163)
ALS (106)
Alzheimer's disease (984)
Antibody-drug conjugate (ADC) (277)
Approvals (10401)
Artificial intelligence (327)
ASCO (159)
Autoimmune disease (216)
Automation (29)
Bankruptcy (263)
Best Places to Work (6960)
BIO (36)
Biologics (9)
BIOSECURE Act (1)
Biosimilars (114)
BioSpace Insights (17)
Biotechnology (88)
Bladder cancer (139)
Brain cancer (30)
Breast cancer (516)
Cancer (3721)
Cardiovascular disease (225)
Career advice (245)
Career pathing (1)
CAR-T (177)
CDMO (10)
Celiac Disease (1)
Cell therapy (483)
Cervical cancer (35)
Clinical research (47991)
Collaboration (1270)
Commercialization (3)
Compensation (1519)
Complete response letters (34)
COVID-19 (758)
CRISPR (64)
C-suite (790)
Cystic fibrosis (86)
Data (5808)
Denatured (4)
Depression (103)
Dermatology (67)
Diabetes (350)
Diagnostics (4202)
Digital health (39)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (158)
Drug pricing (7)
Drug shortages (2)
Duchenne muscular dystrophy (166)
Earnings (73822)
Editorial (1)
Employer branding (2)
Employer resources (14)
Events (88111)
Executive appointments (711)
FDA (12456)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (18)
Frontotemporal dementia (24)
Funding (937)
Gene editing (126)
Generative AI (9)
Gene therapy (329)
GLP-1 (294)
Government (946)
Grass and pollen (2)
Guidances (281)
Healthcare (9369)
Hematology (94)
HIV (53)
Huntington's disease (22)
IgA nephropathy (65)
Immunology and inflammation (101)
Immuno-oncology (61)
Indications (159)
Infectious disease (948)
Inflammatory bowel disease (127)
Inflation Reduction Act (4)
Influenza (84)
Intellectual property (259)
Interviews (41)
IPO (12388)
IRA (2)
Job creations (1968)
Job search strategy (235)
JPM (1)
Kidney cancer (16)
Layoffs (59)
Legal (5201)
Licensing (16)
Liver cancer (45)
Longevity (19)
Lung cancer (521)
Lymphoma (257)
Machine learning (27)
Management (3)
Manufacturing (554)
Marketing (8)
MASH (118)
Medical affairs (2)
Medical device (8689)
Medtech (8844)
Mergers & acquisitions (14402)
Metabolic disorders (718)
mRNA (60)
Multiple sclerosis (106)
NASH (4)
Neurodegenerative disease (224)
Neuropsychiatric disorders (40)
Neuroscience (1852)
NextGen: Class of 2026 (3150)
Non-profit (843)
Obesity (227)
Opinion (10)
Ovarian cancer (161)
Pain (177)
Pancreatic cancer (204)
Parkinson's disease (204)
Partnered (12)
Patents (490)
Patient recruitment (523)
Patient selection (1)
Peanut (31)
People (41362)
Peptides (1)
Pharmaceutical (30)
Pharmacy benefit managers (9)
Phase 1 (15504)
Phase 2 (21425)
Phase 3 (14450)
Pipeline (7604)
Policy (18)
Postmarket research (1570)
Preclinical (6551)
Press Release (34)
Prostate cancer (193)
Psychedelics (7)
Radiopharmaceuticals (194)
Rare diseases (583)
Real estate (3023)
Recruiting (6)
Regulatory (14907)
Reports (23)
Research institute (584)
Resumes & cover letters (45)
Rett syndrome (42)
RNA editing (5)
RSV (48)
Schizophrenia (102)
Series A (158)
Series B (122)
Service/supplier (5)
Sickle cell disease (63)
Spinal muscular atrophy (89)
Sponsored (5)
Startups (2020)
Stomach cancer (3)
Supply chain (51)
Vaccines (332)
Venture capital (17)
Weight loss (74)
Women's health (83)
Date
Last 7 days (372)
Last 30 days (1284)
Last 365 days (19012)
2026 (13339)
2025 (19252)
2024 (22989)
2023 (26544)
2022 (34588)
2021 (37180)
2020 (33472)
2019 (23261)
2018 (17476)
2017 (18777)
2016 (17940)
2015 (24280)
2014 (21700)
2013 (18147)
2012 (20242)
2011 (20460)
2010 (20357)
Location
Africa (228)
Alabama (76)
Alaska (2)
Arizona (309)
Arkansas (11)
Asia (17937)
Australia (2106)
California (12273)
Canada (3217)
China (538)
Colorado (491)
Connecticut (424)
Delaware (211)
Europe (24681)
Florida (1841)
Georgia (391)
Hawaii (3)
Idaho (46)
Illinois (718)
India (52)
Indiana (320)
Iowa (16)
Japan (415)
Kansas (101)
Kentucky (31)
Louisiana (27)
Maine (26)
Maryland (1223)
Massachusetts (8053)
Michigan (312)
Minnesota (568)
Mississippi (4)
Missouri (82)
Montana (20)
Nebraska (11)
Nevada (119)
New Hampshire (60)
New Jersey (2677)
New Mexico (12)
New York (2878)
North Carolina (1311)
North Dakota (4)
Northern California (6169)
Ohio (288)
Oklahoma (14)
Oregon (16)
Pennsylvania (2289)
Puerto Rico (20)
Rhode Island (30)
South America (407)
South Carolina (77)
South Dakota (1)
Southern California (5105)
Tennessee (122)
Texas (1991)
United States (39778)
Utah (367)
Vermont (1)
Virginia (156)
Washington D.C. (38)
Washington State (954)
West Virginia (1)
Wisconsin (74)
Wyoming (1)
485,972 Results for "orthofix inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Orthofix to Report Second Quarter 2026 Financial Results
July 15, 2026
·
1 min read
Press Releases
Orthofix Reports Second Quarter 2026 Results Reflecting Continued Operational Progress
August 5, 2026
·
18 min read
Press Releases
Orthofix to Participate in Upcoming June 2026 Investor Conferences
May 18, 2026
·
1 min read
Press Releases
Orthofix Realigns Spine Leadership to Strengthen Focus and Execution
April 10, 2026
·
8 min read
Press Releases
Orthofix Expands Pediatric Limb Reconstruction Portfolio with New FITBONE™ Innovation at POSNA 2026 Annual Meeting
May 6, 2026
·
5 min read
Press Releases
Orthofix Reports First Quarter 2026 Results Highlighting Steady Execution Following Spine Commercial Channel Actions; Reaffirms Full-Year 2026 Financial Guidance
May 5, 2026
·
17 min read
Press Releases
Orthofix Reports Fourth Quarter and Full-Year 2025 Financial Results and Provides 2026 Financial Guidance
February 24, 2026
·
18 min read
Press Releases
Orthofix Reports Third Quarter 2025 Financial Results
November 5, 2025
·
18 min read
Press Releases
Orthofix to Participate in Upcoming November 2025 Investor Conferences
October 16, 2025
·
1 min read
Press Releases
Orthofix Reports Second Quarter 2025 Financial Results
August 6, 2025
·
18 min read
1 of 48,598
Next
